Skip to main content
OpenTrials

Clinical trial condition

Colitis

Explore clinical trials studying Colitis. Study availability and eligibility vary by location and protocol.

1,255 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Colitis trial results

Recruiting

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

NCT07186101

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Clinnova Research - Anaheim Anaheim, California, United States
  • Om Research LLC Lancaster, California, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
View all 147 locations
View Trial Details
Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

NCT07483073

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Biopharma Informatic, LLC Los Angeles, California, United States
  • Om Research LLC Oxnard, California, United States
  • South Denver Gastroenterology Englewood, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

NCT07415044

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Valleywise Health Medical Center Phoenix, Arizona, United States
  • One of a Kind Clinical Research Center Scottsdale, Arizona, United States
  • Clinnova Research Anaheim, California, United States
  • GMC Clinical Research Folsom, California, United States
View all 259 locations
View Trial Details
Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

NCT07071519

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Phoenix Children's Hospital /ID# 273015 Phoenix, Arizona, United States
  • Rady Children's Hospital /ID# 271873 San Diego, California, United States
  • University of California San Francisco - Mission Bay /ID# 273022 San Francisco, California, United States
  • Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585 Miami, Florida, United States
View all 61 locations
View Trial Details
Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086

Conditions
Body Weight, Colitis, Colitis, Ulcerative, +15 more
Locations
  • Digestive Health Specialists Dothan, Alabama, United States
  • Smart Cures Clinical Research Anaheim, California, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
  • United Medical Doctors - Los Alamitos Los Alamitos, California, United States
View all 187 locations
View Trial Details
Recruiting

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

NCT07697456

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Digestive Health Specialists /ID# 280827 Dothan, Alabama, United States
  • Elite Clinical Studies /ID# 280477 Phoenix, Arizona, United States
  • Clinnova Research /ID# 280509 Anaheim, California, United States
  • Gastro Care Institute /ID# 281071 Lancaster, California, United States
View all 26 locations
View Trial Details
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

NCT07245394

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +10 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • MA MacMillan Fredericton, New Brunswick, Canada
  • Hamilton Health Sciences Corporation Hamilton, Ontaio, Canada
  • Barrie GI Associates Barrie, Ontario, Canada
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

NCT07463183

Conditions
Colitis, Colitis Ulcerative, Colitis, Ulcerative, +7 more
Locations
  • Clinnova Research ( Site 1042) Anaheim, California, United States
  • Peak Gastroenterology Associates ( Site 1052) Colorado Springs, Colorado, United States
  • South Denver Gastroenterology, PC ( Site 1068) Englewood, Colorado, United States
  • Nature Coast Clinical Research ( Site 1045) Inverness, Florida, United States
View all 30 locations
View Trial Details

Related conditions